{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:26:42Z","timestamp":1772706402402,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1996,11,1]],"date-time":"1996-11-01T00:00:00Z","timestamp":846806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1007\/bf01254476","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T16:34:22Z","timestamp":1111595662000},"page":"1508-1513","source":"Crossref","is-referenced-by-count":45,"title":["Visualization of the thymus by substance P receptor scintigraphy in man"],"prefix":"10.1007","volume":"23","author":[{"given":"P. M.","family":"van Hagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A. P.","family":"Breeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Reubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. T. E.","family":"Postema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"van den Anker-Lugtenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Laissue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Waser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. W. J.","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. P.","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/S0021-9258(18)62860-1","volume":"245","author":"MM Chang","year":"1970","unstructured":"Chang MM, Leeman SE. Isolation of a sialogic peptide from bovine hypothalamic tissue and its characterization as substance P. J Biol Chem 1970; 245: 4784?4790.","journal-title":"J Biol Chem"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0167-0115(93)90029-8","volume":"46","author":"DA Walsh","year":"1993","unstructured":"Walsh DA, Salmon M, Wharton J, Mapp PI, Polak JM. Autoradiographic localisation and characterisation of substance P binding sites in rat knees. Regul Pept 1993; 46: 189?192.","journal-title":"Regul Pept"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ard.51.3.313","volume":"51","author":"DA Walsh","year":"1992","unstructured":"Walsh DA, Mapp PI, Salmon M, Rutherford RAD, Kidd BL, Revell PA, Balke DR, Polak JM. Localisation and characterisation of substance P binding to human synovium in rheumatoid arthritis. Ann Rheum Dis 1992; 51: 313?317.","journal-title":"Ann Rheum Dis"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1073\/pnas.85.9.3235","volume":"85","author":"PW Mantyh","year":"1988","unstructured":"Mantyh PW, Gates TS, Zimmerman RP, Welton ML, Passaro RP, Vigna SR, Maggio JE, Kruger L, Mantyh PW. Receptor binding sites for substance P, but not substance K, or neuromidin K, are expressed in high concentrations by arterioles, venules, and lymph nodes in surgical specimens from patients with ulcerative colitis and Crohn's disease. Proc Natl Acad Sci USA 1988; 85: 3235?3239.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1991.tb33114.x","volume":"632","author":"WM Mantyh","year":"1991","unstructured":"Mantyh WM. Substance P and the inflammatory and immune response. Ann NY Acad Sci 1991; 632: 263?271.","journal-title":"Ann NY Acad Sci"},{"key":"CR6","first-page":"951","volume":"267","author":"DA Walsh","year":"1993","unstructured":"Walsh DA, Salmon M, Mapp PI, Wharton J, Garrett N, Blake DR, Polak JM. Microvascular substance P binding to normal and inflamed rat and human synovium. J Pharmacol Exp Ther 1993; 267: 951?960.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR7","first-page":"632","volume":"77","author":"TJ Joyce","year":"1993","unstructured":"Joyce TJ, Yood RA, Carraway RE. Quantitation of substance P and its metabolites in plasma and synovial fluid from patients with arthritis. J Clin Endocrinol Metab 1993; 77: 632?637.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01967311","volume":"13","author":"JC Foreman","year":"1983","unstructured":"Foreman JC, Jordan CC. Histamine release and vascular changes induced by neuropeptides. Agent Actions 1983; 13: 105?116.","journal-title":"Agent Actions"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0196-9781(85)90142-1","volume":"6","author":"MR Ruff","year":"1985","unstructured":"Ruff MR. Wahl SM, Pert CB. Substance P receptor mediated chemotaxis of human monocytes. Peptides 1985; 6: 107?111.","journal-title":"Peptides"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI111567","volume":"74","author":"DG Payan","year":"1984","unstructured":"Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ. Substance P recognition by a subset of human T lymphocytes. J Clin Invest 1984; 74: 1532?1539.","journal-title":"J Clin Invest"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4049\/jimmunol.136.1.152","volume":"136","author":"AM Stanisz","year":"1986","unstructured":"Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986; 136: 152?156.","journal-title":"J Immunol"},{"key":"CR12","first-page":"26","volume-title":"Atlas of tumor pathology, second series, fascicle 13","author":"J Rosai","year":"1976","unstructured":"Rosai J, Levine GD. Tumors of the thymus. In: Atlas of tumor pathology, second series, fascicle 13. Washington DC: Armed Forces Institute of Pathology; 1976; 26?33; 133-137."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","volume":"9","author":"GD Levine","year":"1978","unstructured":"Levine GD, Rosai J. Thymie hyperplasia and neoplasia: a review of concepts. Human Pathol 1978; 9: 495?515.","journal-title":"Human Pathol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01745473","volume":"65","author":"WJ Hoffmann","year":"1987","unstructured":"Hoffmann WJ, Moller P, Otto HE Thymic hyperplasia. II. Lymphoreticular hyperplasia of the thymus. An immunohistologic study. Klin Wochenschr 1987; 65: 53?60.","journal-title":"Klin Wochenschr"},{"key":"CR15","first-page":"56","volume":"22","author":"G Tridente","year":"1985","unstructured":"Tridente G. Immunopathology of the human thymus. Semin Hematol 1985; 22: 56?57.","journal-title":"Semin Hematol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0889-1591(90)90022-I","volume":"4","author":"M Piantelli","year":"1990","unstructured":"Piantelli M, Maggiano N, Larocca LM, Ricci R, Ranelletti FO, Lauriola L, Capelli A. Neuropeptide-immunoreactive cells in the human thymus. Braira Behav Immun 1990; 4: 189?197.","journal-title":"Braira Behav Immun"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0196-9781(90)90162-X","volume":"11","author":"D Lorton","year":"1990","unstructured":"Lorton D, Bellinger DL, Felten SY, Felten DL. Substance P innervation of the rat thymus. Peptides 1990; 11: 1269?1275.","journal-title":"Peptides"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0167-0115(86)90058-3","volume":"16","author":"K Shigematsu","year":"1986","unstructured":"Shigematsu K, Saavedra JM, Kurihara M. Specific substance P binding sites in rat thymus and spleen: in vitro autoradiographie study. Regul Pept 1986; 16: 147?156.","journal-title":"Regul Pept"},{"key":"CR19","first-page":"108","volume":"37","author":"WAP Breeman","year":"1996","unstructured":"Breeman WAP, Van Hagen PM, Visser-Wisselaar HA, van der Pluijm ME, Koper JW, Setyono-Han B, Bakker WH, Kwekke-boom DJ, Hazenberg MP, Lamberts SWJ, Krenning EP. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-lll-DTPA-Arg1]substance P. J Nucl Med 1996; 37: 108?117.","journal-title":"J Nucl Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00176572","volume":"21","author":"WAP Breeman","year":"1994","unstructured":"Breeman WAP, Holland LJ, van der Pluijm M, Koetsveld PM, deJong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SWJ, Krenning EP. A new radiolabelled somatostatin analogue [111ln-DTPA-d-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-d-Phe1]octreotide. Eur J Nucl Med 1994; 21: 328?335.","journal-title":"Eur J Nucl Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0016-5085(94)90754-4","volume":"106","author":"JC Reubi","year":"1994","unstructured":"Reubi JC, Mazzuccheli L, Laissue J. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology 1994; 106: 951?959.","journal-title":"Gastroenterology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ijc.2910610608","volume":"61","author":"IM Hennig","year":"1995","unstructured":"Hennig IM, Laissue JA, Horisberger U, Reubi JC. Substance P receptors in human primary neoplasms: tumoural and vascular localisation. Int J Cancer 1995; 61: 786?792.","journal-title":"Int J Cancer"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000126262","volume":"56","author":"V Coiro","year":"1992","unstructured":"Coiro V Capretti L, Volpi R, Davoli C, Marcato A, Cavazzini U, Caffarri G, Rossi G, Chiodera P. Stimulation of ACTH\/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate. Neuroendocrinology 1992; 56: 459?463.","journal-title":"Neuroendocrinology"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/00365528609015169","volume":"21","author":"OB Schaffalitzky De Muckadel","year":"1986","unstructured":"Schaffalitzky De Muckadel OB, Aggestrup S, Stentoft P. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal men. Scand J Gastroenterol 1986; 21: 498?502.","journal-title":"Scand J Gastroenterol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1471-4159.1993.tb03484.x","volume":"60","author":"CJ Mussap","year":"1993","unstructured":"Mussap CJ, Gerargthy DP, Burcher E. Tachykinin receptors: a radioligand binding perspective. Review. J Neurochem 1993; 60: 1987?2009.","journal-title":"J Neurochem"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/mend-4-8-1211","volume":"4","author":"A Ericsson","year":"1990","unstructured":"Ericsson A, Geenen V Robert F, Legros JJ. Expression of preprotachykinin-A and neuropeptide-Y messenger RNA in the thymus. Mol Endocrinol 1990; 4: 1211?1214.","journal-title":"Mol Endocrinol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.33.10.1276","volume":"33","author":"A Vincent","year":"1983","unstructured":"Vincent A, Newton-Davis J, Newton P, Beck N. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis. Neurology 1983; 33: 1276?1282.","journal-title":"Neurology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0896-8411(91)90018-8","volume":"4","author":"JBM Kuks","year":"1991","unstructured":"Kuks JBM, Oosterhuis HIGH, Limburg PC, The TH. Antiacetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations. J Autoimmun 1991; 4: 197?211.","journal-title":"J Autoimmun"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01254476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01254476\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01254476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T05:06:37Z","timestamp":1706072797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01254476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["BF01254476"],"URL":"https:\/\/doi.org\/10.1007\/bf01254476","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}